Regentis Biomaterials Ltd (RGNT) Price Prediction & ForecastRGNTRegentis Biomaterials Ltd

Alphio's RGNT stock price prediction model matches the current Regentis Biomaterials Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.01 (+0.35%). The 1-week path is $2.01 (+0.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Regentis Biomaterials Ltd is a good buy right now due to its recent funding success and potential market expansion. The stock is currently priced at $2.00, significantly below the analyst target of $10, indicating a potential upside of 400%. Additionally, the stock's recent rise of 29% following the CE Mark approval for GelrinC suggests positive momentum. However, the company has a current ratio of only 0.05, indicating liquidity risks that investors should be aware of.

Regentis Biomaterials Ltd (RGNT) last closed at $2, losing -2.91%. These facts feed the 1-day and 1-week RGNT price prediction above.